Correction to: Propionate represses the dnaA gene via the methylcitrate pathway-regulating transcription factor, PrpR, in Mycobacterium tuberculosis
Correction to: Antonie van Leeuwenhoek (2014) 105:951–959 https://doi.org/10.1007/s10482-014-0153-0
Subsequent to the publication of the above article, it has been noticed that data published in Figure 2A and Figure 2B of this article duplicate images previously published by this research group in the following paper:
Masiewicz P, Brzostek A, Wolański M, Dziadek J, Zakrzewska-Czerwińska J (2012). A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylcitrate Pathway in Mycobacterium tuberculosis. Plos ONE 7(8): e43651. https://doi.org/10.1371/journal.pone.0043651.
Specifically, the electrophoretic mobility shift assay and immunoprecipitation assay data for the pprpDR and pmtrA (respectively, positive and negative controls) in Figure 2A and Figure 2B of the Antonie van Leeuwenhoek paper were previously published in Plos ONE as Figure 2A and Figure 4AC, respectively, in that paper. Moreover, in Figure 2B of the Antonie van Leeuwenhoek paper, the pdnaA panel appears to duplicate the Figure 4B picI1 panel of the Plos ONE paper. In this case, we can confirm that the data given in the Antonie van Leeuwenhoek paper for pdnaA are the correct image. The authors confirm that these corrections do not alter the findings presented in the Antonie van Leeuwenhoek paper or the conclusions drawn from them.
We regret that the authors did not credit the original source of the figures published in Masiewicz et al. (2014). We hereby acknowledge and correct this oversight.
Additionally, the name of program and organisation which supported the research was published incorrectly. Now, it should read: “The research was supported by Wroclaw Research Centre EIT+ under the project “Biotechnologies and advanced medical technologies”—BioMed (POIG.01.01.02-02-003/08) financed from the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2)”.